Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in the tumor's genome.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Precision Cancer Diagnostic Tests industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Market Segment by Product Application
Hospital
Clinic
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio-Rad Laboratories
Biocartis N.V.
Biocept
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics AG
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic
Illumina
Menarini Silicon Biosystems SpA
Myriad Genetics
NanoString Technologies
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Precision Cancer Diagnostic Tests consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Precision Cancer Diagnostic Tests market by identifying its various subsegments.
3.Focuses on the key global Precision Cancer Diagnostic Tests manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Precision Cancer Diagnostic Tests with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Precision Cancer Diagnostic Tests submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Precision Cancer Diagnostic Tests Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Precision Cancer Diagnostic Tests Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Precision Cancer Diagnostic Tests Segment by Type
2.1.1 Imaging
2.1.2 Molecular
2.1.3 Histology/Cytology
2.1.4 Tumor Marker Immunoassays
2.1.5 POC Colon Cancer Tests
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Other
2.3 Global Precision Cancer Diagnostic Tests Market Comparison by Regions (2017-2027)
2.3.1 Global Precision Cancer Diagnostic Tests Market Size (2017-2027)
2.3.2 North America Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.3.3 Europe Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.3.4 China Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.3.5 Japan Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.3.6 Southeast Asia Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Precision Cancer Diagnostic Tests Industry Impact
2.5.1 Precision Cancer Diagnostic Tests Business Impact Assessment - Covid-19
2.5.2 Market Trends and Precision Cancer Diagnostic Tests Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Precision Cancer Diagnostic Tests Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Precision Cancer Diagnostic Tests Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Precision Cancer Diagnostic Tests Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Precision Cancer Diagnostic Tests Manufacturer Market Share
3.5 Top 10 Precision Cancer Diagnostic Tests Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Precision Cancer Diagnostic Tests Market
3.7 Key Manufacturers Precision Cancer Diagnostic Tests Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Precision Cancer Diagnostic Tests Industry Key Manufacturers
4.1 Abbott Laboratories
4.1.1 Compan Detail
4.1.2 Abbott Laboratories Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.1.3 Abbott Laboratories 178 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Abbott Laboratories News
4.2 Agilent Technologies
4.2.1 Compan Detail
4.2.2 Agilent Technologies Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Abbott Laboratories News
4.3 Becton Dickinson and Company
4.3.1 Compan Detail
4.3.2 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Becton Dickinson and Company News
4.4 Bio-Rad Laboratories
4.4.1 Compan Detail
4.4.2 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Bio-Rad Laboratories News
4.5 Biocartis N.V.
4.5.1 Compan Detail
4.5.2 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Biocartis N.V. News
4.6 Biocept
4.6.1 Compan Detail
4.6.2 Biocept Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.6.3 Biocept Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Biocept News
4.7 bioMerieux SA
4.7.1 Compan Detail
4.7.2 bioMerieux SA Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Canon Medical Systems Corporation
4.8.1 Compan Detail
4.8.2 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Canon Medical Systems Corporation News
4.9 Cynvenio Biosystems
4.9.1 Compan Detail
4.9.2 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Cynvenio Biosystems News
4.10 Danaher Corporation
4.10.1 Compan Detail
4.10.2 Danaher Corporation Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Danaher Corporation News
4.11 Epigenomics AG
4.11.1 Compan Detail
4.11.2 Epigenomics AG Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Epigenomics AG News
4.12 Exosome Diagnostics
4.12.1 Compan Detail
4.12.2 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Exosome Diagnostics News
4.13 Foundation Medicine
4.13.1 Company Details
4.13.2 Foundation Medicine Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Foundation Medicine News
4.14 General Electric Company
4.14.1 Compan Detail
4.14.2 General Electric Company Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.14.3 General Electric Company Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 General Electric Company News
4.15 Genomic Health
4.15.1 Compan Detail
4.15.2 Genomic Health Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.15.3 Genomic Health Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Genomic Health News
4.16 Hologic
4.16.1 Compan Detail
4.16.2 Hologic Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.16.3 Hologic Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Hologic News
4.17 Illumina
4.17.1 Compan Detail
4.17.2 Illumina Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.17.3 Illumina Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Illumina News
4.18 Menarini Silicon Biosystems SpA
4.18.1 Compan Detail
4.18.2 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Menarini Silicon Biosystems SpA News
4.19 Myriad Genetics
4.19.1 Compan Detail
4.19.2 Myriad Genetics Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Myriad Genetics News
4.20 NanoString Technologies
4.20.1 Compan Detail
4.20.2 NanoString Technologies Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 NanoString Technologies News
4.21 Ortho Clinical Diagnostics
4.21.1 Compan Detail
4.21.2 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.21.4 Main Business Overview
4.21.5 Ortho Clinical Diagnostics News
4.22 QIAGEN N.V.
4.22.1 Compan Detail
4.22.2 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.22.4 Main Business Overview
4.22.5 QIAGEN N.V. News
4.23 Randox Laboratories Ltd.
4.23.1 Compan Detail
4.23.2 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.23.4 Main Business Overview
4.23.5 Randox Laboratories Ltd. News
4.24 Roche Holding AG
4.24.1 Compan Detail
4.24.2 Roche Holding AG Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.24.4 Main Business Overview
4.24.5 Roche Holding AG News
4.25 Royal Philips N.V.
4.25.1 Compan Detail
4.25.2 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.25.4 Main Business Overview
4.25.5 Royal Philips N.V. News
4.26 Siemens AG
4.26.1 Compan Detail
4.26.2 Siemens AG Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.26.3 Siemens AG Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.26.4 Main Business Overview
4.26.5 Siemens AG News
4.27 Thermo Fisher Scientific
4.27.1 Compan Detail
4.27.2 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.27.4 Main Business Overview
4.27.5 Thermo Fisher Scientific News
4.28 Vela Diagnostics
4.28.1 Compan Detail
4.28.2 Vela Diagnostics Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.28.4 Main Business Overview
4.28.5 Vela Diagnostics News
5 Global Precision Cancer Diagnostic Tests Market Segment by Big Type
5.1 Global Precision Cancer Diagnostic Tests Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Precision Cancer Diagnostic Tests Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Precision Cancer Diagnostic Tests Revenue and Market Share by Big Type (2017-2022)
5.2 Imaging Sales Growth Rate and Price
5.2.1 Global Imaging Sales Growth Rate (2017-2022)
5.2.2 Global Imaging Price (2017-2022)
5.3 Molecular Sales Growth Rate and Price
5.3.1 Global Molecular Sales Growth Rate (2017-2022)
5.3.2 Global Molecular Price (2017-2022)
5.4 Histology/Cytology Sales Growth Rate and Price
5.4.1 Global Histology/Cytology Sales Growth Rate (2017-2022)
5.4.2 Global Histology/Cytology Price (2017-2022)
5.5 Tumor Marker Immunoassays Sales Growth Rate and Price
5.5.1 Global Tumor Marker Immunoassays Sales Growth Rate (2017-2022)
5.5.2 Global Tumor Marker Immunoassays Price (2017-2022)
5.6 POC Colon Cancer Tests Sales Growth Rate and Price
5.6.1 Global POC Colon Cancer Tests Sales Growth Rate (2017-2022)
5.6.2 Global POC Colon Cancer Tests Price (2017-2022)
6 Global Precision Cancer Diagnostic Tests Market Segment by Big Application
6.1 Global Precision Cancer Diagnostic Tests Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Clinic Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Precision Cancer Diagnostic Tests Forecast
7.1 Global Precision Cancer Diagnostic Tests Revenue, Sales and Growth Rate (2022-2027)
7.2 Precision Cancer Diagnostic Tests Market Forecast by Regions (2022-2027)
7.2.1 North America Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
7.2.2 Europe Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
7.2.3 China Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
7.2.4 Japan Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
7.2.5 Southeast Asia Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
7.2.6 Other Regions Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
7.3 Precision Cancer Diagnostic Tests Market Forecast by Type (2022-2027)
7.3.1 Global Precision Cancer Diagnostic Tests Sales Forecast by Type (2022-2027)
7.3.2 Global Precision Cancer Diagnostic Tests Market Share Forecast by Type (2022-2027)
7.4 Precision Cancer Diagnostic Tests Market Forecast by Application (2022-2027)
7.4.1 Global Precision Cancer Diagnostic Tests Sales Forecast by Application (2022-2027)
7.4.2 Global Precision Cancer Diagnostic Tests Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Precision Cancer Diagnostic Tests Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Precision Cancer Diagnostic Tests Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Precision Cancer Diagnostic Tests
Figure Market Concentration Ratio and Market Maturity Analysis of Precision Cancer Diagnostic Tests
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Precision Cancer Diagnostic Tests Market Size by Big Type
Figure Global Market Share of Precision Cancer Diagnostic Tests by Big Type in 2021
Figure Imaging Picture (2017-2022)
Figure Molecular Picture (2017-2022)
Figure Histology/Cytology Picture (2017-2022)
Figure Tumor Marker Immunoassays Picture (2017-2022)
Global Precision Cancer Diagnostic Tests Market Size by Big Application
Table Global Precision Cancer Diagnostic Tests Market Size by Application
Figure Global Precision Cancer Diagnostic Tests Market Share by Big Application in 2021
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Precision Cancer Diagnostic Tests Comparison by Regions (M USD) (2017-2027)
Figure Global Precision Cancer Diagnostic Tests Market Size (Million US$) (2017-2027)
Figure North America Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Figure China Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Precision Cancer Diagnostic Tests Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Precision Cancer Diagnostic Tests Sales by Manufacturer (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Sales Market Share by Manufacturer in 2021
Table Global Precision Cancer Diagnostic Tests Revenue by Manufacturer (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturer in 2021
Table Global Precision Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Precision Cancer Diagnostic Tests Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Precision Cancer Diagnostic Tests Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Precision Cancer Diagnostic Tests Market
Table Key Manufacturers Precision Cancer Diagnostic Tests Product Type
Table Mergers & Acquisitions Planning
Table Abbott Laboratories Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Abbott Laboratories
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Agilent Technologies Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Agilent Technologies
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Agilent Technologies Recent Development
Table Becton Dickinson and Company Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Becton Dickinson and Company
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Becton Dickinson and Company Main Business
Table Becton Dickinson and Company Recent Development
Table Bio-Rad Laboratories Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Bio-Rad Laboratories
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bio-Rad Laboratories Main Business
Table Bio-Rad Laboratories Recent Development
Table Bio-Rad Laboratories Main Business
Table Bio-Rad Laboratories Recent Development
Table Biocartis N.V. Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Biocartis N.V.
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biocartis N.V. Main Business
Table Biocartis N.V. Recent Development
Table Biocept Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Biocept
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biocept Main Business
Table Biocept Recent Development
Table bioMerieux SA Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of bioMerieux SA
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table bioMerieux SA Main Business
Table bioMerieux SA Recent Development
Table Canon Medical Systems Corporation Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Canon Medical Systems Corporation
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Canon Medical Systems Corporation Main Business
Table Canon Medical Systems Corporation Recent Development
Table Cynvenio Biosystems Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Cynvenio Biosystems
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cynvenio Biosystems Main Business
Table Cynvenio Biosystems Recent Development
Table Danaher Corporation Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Danaher Corporation
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Danaher Corporation Main Business
Table Danaher Corporation Recent Development
Table Epigenomics AG Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Epigenomics AG
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Epigenomics AG Main Business
Table Epigenomics AG Recent Development
Table Exosome Diagnostics Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Exosome Diagnostics
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Exosome Diagnostics Main Business
Table Exosome Diagnostics Recent Development
Table Foundation Medicine Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Foundation Medicine
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Foundation Medicine Main Business
Table Foundation Medicine Recent Development
Table General Electric Company Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of General Electric Company
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table General Electric Company Main Business
Table General Electric Company Recent Development
Table Hologic Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Hologic
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hologic Main Business
Table Hologic Recent Development
Table Illumina Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Illumina
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Illumina Main Business
Table Illumina Recent Development
Table Menarini Silicon Biosystems SpA Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Menarini Silicon Biosystems SpA
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Menarini Silicon Biosystems SpA Main Business
Table Menarini Silicon Biosystems SpA Recent Development
Table Myriad Genetics Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Myriad Genetics
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Myriad Genetics Main Business
Table Myriad Genetics Recent Development
Table NanoString Technologies Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of NanoString Technologies
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table NanoString Technologies Main Business
Table NanoString Technologies Recent Development
Table Ortho Clinical Diagnostics Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Ortho Clinical Diagnostics
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ortho Clinical Diagnostics Main Business
Table Ortho Clinical Diagnostics Recent Development
Table QIAGEN N.V. Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of QIAGEN N.V.
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table QIAGEN N.V. Main Business
Table QIAGEN N.V. Recent Development
Table Randox Laboratories Ltd. Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Randox Laboratories Ltd.
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Randox Laboratories Ltd. Main Business
Table Randox Laboratories Ltd. Recent Development
Table Roche Holding AG Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Roche Holding AG
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Holding AG Main Business
Table Roche Holding AG Recent Development
Table Royal Philips N.V. Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Royal Philips N.V.
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Royal Philips N.V. Main Business
Table Royal Philips N.V. Recent Development
Table Siemens AG Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Siemens AG
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Siemens AG Main Business
Table Siemens AG Recent Development
Table Thermo Fisher Scientific Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Thermo Fisher Scientific
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Thermo Fisher Scientific Main Business
Table Thermo Fisher Scientific Recent Development
Table Vela Diagnostics Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Vela Diagnostics
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Vela Diagnostics Main Business
Table Vela Diagnostics Recent Development
Figure Global Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Revenue and Growth Rate (2017-2022)
Table Global Precision Cancer Diagnostic Tests Sales by Regions (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Sales Market Share by Regions in 2021
Table Global Precision Cancer Diagnostic Tests Revenue by Regions (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Revenue Market Share by Regions in 2021
Figure North America Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
Figure Europe Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
Figure China Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
Figure Japan Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
Figure Southeast Asia Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
Figure Other Regions Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
Table Global Precision Cancer Diagnostic Tests Sales by Big Type (2017-2022)
Table Global Precision Cancer Diagnostic Tests Sales Market Share by Big Type (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Sales Market Share by Big Type in 2019
Table Global Precision Cancer Diagnostic Tests Revenue by Big Type (2017-2022)
Table Global Precision Cancer Diagnostic Tests Revenue Market Share by Big Type (2017-2022)
Table Global Precision Cancer Diagnostic Tests Revenue Market Share by Big Type in 2019
Figure Global Imaging Sales Growth Rate (2017-2022)
Figure Global Imaging Price (2017-2022)
Figure Global Molecular Sales Growth Rate (2017-2022)
Figure Global Molecular Price (2017-2022)
Figure Global Histology/Cytology Sales Growth Rate (2017-2022)
Figure Global Histology/Cytology Price (2017-2022)
Figure Global Tumor Marker Immunoassays Sales Growth Rate (2017-2022)
Figure Global Tumor Marker Immunoassays Price (2017-2022)
Table Global Precision Cancer Diagnostic Tests Sales by Big Application (2017-2022)
Table Global Precision Cancer Diagnostic Tests Sales Market Share by Big Application (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Sales and Growth Rate (2022-2027)
Figure Global Precision Cancer Diagnostic Tests Revenue and Growth Rate (2022-2027)
Table Global Precision Cancer Diagnostic Tests Sales Forecast by Regions (2022-2027)
Table Global Precision Cancer Diagnostic Tests Market Share Forecast by Regions (2022-2027)
Figure North America Sales Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
Figure Europe Sales Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
Figure China Sales Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
Figure Japan Sales Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
Figure Southeast Asia Sales Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
Figure Other Regions Sales Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
Table Global Precision Cancer Diagnostic Tests Sales Forecast by Type (2022-2027)
Table Global Precision Cancer Diagnostic Tests Market Share Forecast by Type (2022-2027)
Table Global Precision Cancer Diagnostic Tests Sales Forecast by Application (2022-2027)
Table Global Precision Cancer Diagnostic Tests Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio-Rad Laboratories
Biocartis N.V.
Biocept
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics AG
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic
Illumina
Menarini Silicon Biosystems SpA
Myriad Genetics
NanoString Technologies
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG